Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

A DRUG that shrinks tumours in patients with untreatable prostate cancer has shown “remarkable” results, scientists have said. The treatment, called VIR-5500, harnesses the body’s ...

Low-intensity extracorporeal shock wave therapy (LI-SWT) did not improve erectile dysfunction compared to a sham procedure in radical prostatectomy patients. Fewer than 20% of men in the LI-SWT group ...

A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

12. Candy B, Jones L, Williams R, et al. Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: findings from a Cochrane systematic ...

First-line treatments for erectile dysfunction (ED) are being under-prescribed in men with prostate cancer despite strong ...

Add Yahoo as a preferred source to see more of our stories on Google. Kenny Logan has opened up about his recovery, and the revival of his sex life, after undergoing treatment for prostate cancer. The ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

NEW YORK (Reuters Health) - A new study shows that a substantial minority of men receiving so-called androgen deprivation therapy, or ADT, for prostate cancer experience erectile dysfunction (ED).